India board revokes Roche hepatitis patent
The Intellectual Property Appellate Board overturned the patent awarded by the Indian Patent Office to Hoffmann-La Roche's drug Pegasys used to treat hepatitis C -- a disease that can lead to fatal liver problems. While Roche can still challenge the ...
Roche's Hepatitis C drug patent revokedTimes of India
Roche patent on hepatitis C drug nixedDaily News & Analysis
IPAB sets aside Indian patent for Roche's Hepatitis C drugBusiness Standard

all 29 news articles »